Doctor profile · Federal record

Dr. Ashley Beall, MD

Rheumatology Physician (CMS: Rheumatology) · Rockville, MD

  • NPI 1164443511
  • Accepts Medicare
  • MIPS 77.1 / 100 · 2023
  • 27 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
14995 Shady Grove RD Ste 250
Rockville, MD 208508726
(301) 942-7600
fax (301) 217-9241
Mailing address
7361 Calhoun Pl Ste 600
Rockville, MD 208552788

Credentials & registration

NPPES · NUCC
NPI registered
July 2006 — 20 yrs on file
Profile last updated
February 5, 2026
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Maryland #D0067159

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1164443511. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
74,291
Distinct HCPCS
10
Medicare allowed
$1,298,261
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 21,960 14 $6
J3111 Injection, romosozumab-aqqg, 1 mg 17,640 38 $10
J0897 Injection, denosumab, 1 mg 12,060 162 $23
J1602 Injection, golimumab, 1 mg, for intravenous use 4,800 15 $13
J7320 Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg 3,725 25 $7
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 2,900 13 $41
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,240 15 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 937 510 $145
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 910 11 $34
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 604 99 $1

In context: peer comparison

Among 8 peers in Rockville Rheumatology Physician, average services per provider: 1,219. This provider delivers 61× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$213
Transactions
4
Manufacturers
4
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 1 $137.40
Pacira Pharmaceuticals Incorporated 1 $36.25
AstraZeneca Pharmaceuticals Lp 1 $21.49
Lilly USA, LLC 1 $17.38

By nature of payment

Food and Beverage
$213

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
764
Patients
267
Total drug cost
$23,002
Drug Type Claims Patients Total cost
Gabapentin Generic 92 39 $1,506
Hydroxychloroquine Sulfate Generic 91 30 $7,997
Prednisone Generic 91 32 $580
Methotrexate (Methotrexate Sodium) Brand 86 29 $2,412
Allopurinol Generic 69 23 $900
Celecoxib Generic 58 21 $3,138
Tramadol Hcl Generic 57 20 $424
Diclofenac Sodium Generic 51 19 $2,056
Cyclobenzaprine Hcl Generic 35 16 $256
Alendronate Sodium Generic 32 0 $236

Frequently asked questions

Auto-generated from federal data
What is Dr. Ashley Beall's medical specialty?
Dr. Ashley Beall practices Rheumatology Physician in Rockville, MD.
Where does Dr. Ashley Beall practice?
Dr. Ashley Beall practices at 14995 Shady Grove RD Ste 250, Rockville, MD 208508726. Office phone: 3019427600.
What is Dr. Ashley Beall's NPI?
Dr. Ashley Beall's National Provider Identifier (NPI) is 1164443511, issued by NPPES.
Does Dr. Ashley Beall accept Medicare assignment?
Yes. Dr. Ashley Beall accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ashley Beall commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.